Invizyne Technologies Inc. (NASDAQ:IZTC - Get Free Report) was down 4.2% during trading on Wednesday . The company traded as low as $12.56 and last traded at $12.56. Approximately 13,992 shares traded hands during mid-day trading, a decline of 63% from the average daily volume of 37,617 shares. The stock had previously closed at $13.11.
Invizyne Technologies Stock Performance
The business's 50 day moving average is $15.74.
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the stock. Citadel Advisors LLC acquired a new position in shares of Invizyne Technologies in the 4th quarter worth $456,000. Geode Capital Management LLC acquired a new position in shares of Invizyne Technologies in the 4th quarter valued at $277,000. Finally, BNP Paribas Financial Markets purchased a new position in Invizyne Technologies in the 4th quarter worth about $35,000.
Invizyne Technologies Company Profile
(
Get Free Report)
Invizyne Technologies Inc is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc is based in Monrovia, CA.
Featured Articles
Before you consider Invizyne Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Invizyne Technologies wasn't on the list.
While Invizyne Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
